“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better

€3.03

SKU: product-article-8468 Category: General

Description
Reviews (0)

Description

Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better

Reviews

There are no reviews yet.

Be the first to review “Article: Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better”

You must be logged in to post a review.

Top

Article: Interventions in non-metastatic castration-resistant prostate cancer: earlier seems better

Description

Reviews

Related products

Article: Highlights in urologic cancer

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in digestive oncology

Article: Highlights in gynaecological cancers